What Is GMP in Pharmaceutical Manufacturing? A Distributor and Pharmacist Guide

GMP in one paragraph

Good Manufacturing Practice (GMP) is the international standard that defines how pharmaceuticals must be produced so that every pack a patient swallows is identical to every other pack of the same product. In Nigeria the standard is enforced by NAFDAC under the WHO GMP framework, and a manufacturer cannot lawfully produce regulated pharmaceuticals without being GMP-compliant. "GMP certified" is shorthand for "has passed a NAFDAC inspection and is operating under documented procedures the agency has approved" — not a one-time certificate but a continuous status that can be suspended or withdrawn.

Why GMP exists — and why it matters to distributors

Without GMP, two packs of the same labelled product could contain different active ingredient doses, different impurity profiles, or different stability characteristics. A patient taking the lower-dose pack might fail to recover; one taking the higher-dose pack might be harmed. For distributors this translates into:

• Product consistency — every carton you sell behaves like every other carton, which protects your customer relationships.
• Shelf-life reliability — GMP-compliant products carry honest expiry dates because the stability data underpinning them was generated under controlled conditions.
• Regulatory cover — if a complaint reaches NAFDAC, your manufacturer's batch records can trace the product back to a specific production run, which protects everyone in the supply chain.
• Recall capability — when something does go wrong (it occasionally does, even at the best plants), a GMP-compliant manufacturer can identify and recall a specific batch instead of pulling the whole product.

If a manufacturer cannot give you a batch number, expiry date and matching invoice for every consignment, they cannot meaningfully claim GMP compliance.

The ten pillars NAFDAC inspects

NAFDAC GMP inspections at a Nigerian pharmaceutical factory cover ten functional areas. Each is scored, and a single critical failure in any area can suspend production.

1. Premises and layout — physical separation of production areas, controlled environmental conditions (temperature, humidity, particulate counts in tablet halls), one-way personnel and material flow to prevent cross-contamination.
2. Personnel — qualified pharmacists supervising production, documented training records for every employee, health checks, gowning and hygiene protocols.
3. Equipment — calibrated, maintained, qualified for the products being made. Cleaning validated between products. Logbooks for every machine.
4. Raw materials — every batch of incoming API and excipient tested against pharmacopoeial specifications before release to production. Suppliers are audited and approved.
5. Production — written, approved master formulae for every product. Each batch produced exactly to that formula, with every step recorded in real time.
6. Quality Control (QC) — independent QC laboratory testing every batch before release. Assay, dissolution, uniformity, microbial limits, identity. Retained samples for every batch.
7. Documentation — Standard Operating Procedures (SOPs) for every activity. Batch Manufacturing Records (BMRs) for every batch. Validation reports for every process. Documents controlled and auditable.
8. Complaints handling — system to receive, investigate and respond to product complaints from the market.
9. Recalls — documented, tested ability to retrieve a specific batch from the market within a defined time.
10. Self-inspection — the manufacturer audits itself on a defined cycle and corrects deficiencies before NAFDAC arrives.

How a NAFDAC GMP inspection actually runs

A typical NAFDAC GMP audit at a Nigerian pharmaceutical plant looks something like this:

• A team of NAFDAC inspectors (typically 2-4 people including pharmacists and QA specialists) arrives on a scheduled or unannounced visit.
• Opening meeting with the company superintendent pharmacist and QA head.
• Facility walkthrough — tablet hall, granulation, packaging, warehouse, QC lab, change rooms.
• Document review — SOPs, BMRs for recent batches, validation files, training records, equipment logs, complaint files, recall records, self-inspection reports.
• Personnel interviews — operators are asked to demonstrate procedures they should know by memory.
• Sample collection — finished product samples may be taken for independent QC testing at a NAFDAC lab.
• Closing meeting — findings are categorised (critical, major, minor) and a corrective-action timeline is agreed.

The inspection cycle is typically every 2-3 years for established plants, with follow-up visits if findings need verification.

How distributors can verify GMP status before signing

You do not need to be a regulator to verify a manufacturer's GMP status. Five practical checks:

1. Confirm the company has NAFDAC manufacturer registration — every NAFDAC-registered product has a registration number traceable to a registered manufacturer. Our verification guide covers exactly how.
2. Ask for a sample Batch Manufacturing Record (BMR) — a real GMP-compliant manufacturer can show you a redacted BMR for a recent batch on request. If they cannot or will not, walk away.
3. Visit the facility — Nigerian pharmaceutical plants generally welcome serious distributor visits. A GMP-compliant plant will have visible gowning, controlled access, an on-site QC lab, and a superintendent pharmacist who can speak fluently about their batch release process.
4. Request the most recent NAFDAC inspection summary — manufacturers should be willing to share at least a redacted overview confirming when their last inspection was and whether they hold current GMP status.
5. Check product batch traceability — every pack you receive should carry a batch number that the manufacturer can map back to a specific production date, production line, raw material lot and QC release certificate.

Red flags that suggest a manufacturer is not genuinely GMP-compliant

• Refusal to allow a facility visit or to share basic GMP documentation.
• Inconsistent batch number formats, missing expiry dates, or batch numbers that cannot be traced back.
• Products sold without a NAFDAC registration number printed on the immediate container.
• Quality problems showing up at the pack level — broken blisters, smudged printing, inconsistent tablet appearance between cartons of the same SKU.
• Pricing that is suspiciously below the rest of the market for an identical generic — at a certain point this signals cut corners somewhere.

GMP at Dizpharm

Dizpharm Nigeria Limited has operated its Ibusa, Delta State facility under NAFDAC + WHO GMP since 1986. The plant runs separate tablet, liquid and packaging lines under documented SOPs, an on-site QC laboratory tests every batch before release, and every product carries a NAFDAC registration number printed on the immediate container. Distributors are welcome to visit. See our statistics page for the verifiable operational figures, or contact us on WhatsApp to arrange a facility tour.

Frequently asked questions